Corpus Intelligence IC Memo — SACRED HEART HOSPITAL 2026-04-26 15:55 UTC
IC Memo — SACRED HEART HOSPITAL
Investment Committee Memorandum | WI | 156 beds | Grade B | EBITDA uplift $15.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SACRED HEART HOSPITAL

CCN 520013 | EAU CLAIRE, WI | 156 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SACRED HEART HOSPITAL is a 156-bed suburban community hospital in EAU CLAIRE, WI with $208.0M in net patient revenue and a -12.2% operating margin. The hospital serves a payer mix of 35.2% Medicare, 6.4% Medicaid, and 58.3% commercial.

Thesis: Undervalued. Our ML models identify $15.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.2% to -4.9% (+736bps).

Net Revenue HCRIS$208.0M
Current EBITDA COMPUTED$-25.4M
Operating Margin COMPUTED-12.2%
Occupancy HCRIS53.0%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS37.0%
Distress Probability ML49.1%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
34
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -12.2% places it below the state median. Among 34 size-comparable peers (78-312 beds), the median margin is 2.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (78-312), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SACRED HEART HOSPITAL (Target)WI156$208.0M-12.2%
CHILDRENS HOSPITAL OF WISCONSIWI298$795.1M5.0%
MARSHFIELD MEDICAL CENTERWI194$765.7M-13.0%
MCHS EAU CLAIRE HOSPITALWI186$676.4M-5.5%
BELLIN MEMORIAL HOSPITALWI175$652.3M13.7%
ST. VINCENT HOSPITALWI237$649.4M1.9%
ASPIRUS WAUSAU HOSPITALWI239$645.7M3.1%
AURORA BAYCARE MEDICAL CENTERWI190$558.0M17.6%
WAUKESHA MEMORIAL HOSPITALWI270$545.6M3.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.4M+210bp18mo
Cost to Collect4.5%2.5%$4.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.5M+122bp9mo
Clean Claim Rate88.0%96.0%$133K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.4M
Cost to Collect
$4.2M
Denial Rate Reduction
$4.1M
A/R Days Reduction
$2.5M
Clean Claim Rate
$133K
Total EBITDA Uplift$15.3M
Current EBITDA$-25.4M
+ RCM Uplift+$15.3M
Pro Forma EBITDA$-10.1M
Current Margin-12.2%
Pro Forma Margin-4.9%
WC Released (1x)$8.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-39.1M$-14.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-39.1M$-28.6M0.00x-100.0%
Bull Case9.0x11.0x$-35.2M$9.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-35.2M$-361K0.00x-100.0%
Bear Case11.0x10.0x$-43.0M$-78.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-43.0M$-100.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 78-312 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-7.4% / P50=2.5% / P75=12.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.